Cargando…

Long term trends of breast cancer incidence according to proliferation status

BACKGROUND: Long-term breast cancer incidence trends according to proliferation status are poorly described. We studied time-trends in breast cancer incidence, using mitotic count and Ki-67 as markers of proliferation. METHODS: Among 83,298 Norwegian women followed for breast cancer occurrence 1961–...

Descripción completa

Detalles Bibliográficos
Autores principales: Klæstad, Elise, Opdahl, Signe, Raj, Sunil Xavier, Bofin, Anna Mary, Valla, Marit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773605/
https://www.ncbi.nlm.nih.gov/pubmed/36544164
http://dx.doi.org/10.1186/s12885-022-10438-1
_version_ 1784855228760195072
author Klæstad, Elise
Opdahl, Signe
Raj, Sunil Xavier
Bofin, Anna Mary
Valla, Marit
author_facet Klæstad, Elise
Opdahl, Signe
Raj, Sunil Xavier
Bofin, Anna Mary
Valla, Marit
author_sort Klæstad, Elise
collection PubMed
description BACKGROUND: Long-term breast cancer incidence trends according to proliferation status are poorly described. We studied time-trends in breast cancer incidence, using mitotic count and Ki-67 as markers of proliferation. METHODS: Among 83,298 Norwegian women followed for breast cancer occurrence 1961–2012, 2995 incident breast cancers were diagnosed. Ki-67 was assessed using immunohistochemistry on tissue microarrays and mitoses were counted on whole sections. We compared incidence rates according to proliferation status among women born 1886–1928 and 1929–1977, estimating age-specific incidence rate ratios. We performed multiple imputations to account for unknown proliferation status. Mean values of Ki-67 and mitotic counts were calculated, according to age and birth year. We performed separate incidence analyses for HER2(+) and triple negative breast cancers. RESULTS: Among women aged 40–69 years, incidence rates of tumours with low-proliferative activity were higher among those born in 1929 or later, compared to before 1929, according to Ki-67 and mitotic count. Incidence rates of tumours with high-proliferative activity were also higher in women born in 1929 or later compared to before 1929 according to Ki-67, but not according to mitotic count. Mean values of Ki-67 and mitotic count varied according to age and birth year. In subtype-specific analyses we found an increase of high-proliferative HER2(+) tumours according to Ki-67 in women born in 1929 or later, compared to before 1929. CONCLUSIONS: There has been a temporal increase in both low- and high-proliferative breast cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10438-1.
format Online
Article
Text
id pubmed-9773605
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97736052022-12-23 Long term trends of breast cancer incidence according to proliferation status Klæstad, Elise Opdahl, Signe Raj, Sunil Xavier Bofin, Anna Mary Valla, Marit BMC Cancer Research BACKGROUND: Long-term breast cancer incidence trends according to proliferation status are poorly described. We studied time-trends in breast cancer incidence, using mitotic count and Ki-67 as markers of proliferation. METHODS: Among 83,298 Norwegian women followed for breast cancer occurrence 1961–2012, 2995 incident breast cancers were diagnosed. Ki-67 was assessed using immunohistochemistry on tissue microarrays and mitoses were counted on whole sections. We compared incidence rates according to proliferation status among women born 1886–1928 and 1929–1977, estimating age-specific incidence rate ratios. We performed multiple imputations to account for unknown proliferation status. Mean values of Ki-67 and mitotic counts were calculated, according to age and birth year. We performed separate incidence analyses for HER2(+) and triple negative breast cancers. RESULTS: Among women aged 40–69 years, incidence rates of tumours with low-proliferative activity were higher among those born in 1929 or later, compared to before 1929, according to Ki-67 and mitotic count. Incidence rates of tumours with high-proliferative activity were also higher in women born in 1929 or later compared to before 1929 according to Ki-67, but not according to mitotic count. Mean values of Ki-67 and mitotic count varied according to age and birth year. In subtype-specific analyses we found an increase of high-proliferative HER2(+) tumours according to Ki-67 in women born in 1929 or later, compared to before 1929. CONCLUSIONS: There has been a temporal increase in both low- and high-proliferative breast cancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10438-1. BioMed Central 2022-12-21 /pmc/articles/PMC9773605/ /pubmed/36544164 http://dx.doi.org/10.1186/s12885-022-10438-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Klæstad, Elise
Opdahl, Signe
Raj, Sunil Xavier
Bofin, Anna Mary
Valla, Marit
Long term trends of breast cancer incidence according to proliferation status
title Long term trends of breast cancer incidence according to proliferation status
title_full Long term trends of breast cancer incidence according to proliferation status
title_fullStr Long term trends of breast cancer incidence according to proliferation status
title_full_unstemmed Long term trends of breast cancer incidence according to proliferation status
title_short Long term trends of breast cancer incidence according to proliferation status
title_sort long term trends of breast cancer incidence according to proliferation status
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773605/
https://www.ncbi.nlm.nih.gov/pubmed/36544164
http://dx.doi.org/10.1186/s12885-022-10438-1
work_keys_str_mv AT klæstadelise longtermtrendsofbreastcancerincidenceaccordingtoproliferationstatus
AT opdahlsigne longtermtrendsofbreastcancerincidenceaccordingtoproliferationstatus
AT rajsunilxavier longtermtrendsofbreastcancerincidenceaccordingtoproliferationstatus
AT bofinannamary longtermtrendsofbreastcancerincidenceaccordingtoproliferationstatus
AT vallamarit longtermtrendsofbreastcancerincidenceaccordingtoproliferationstatus